Christopher G. Twitty
Chief Tech/Sci/R&D Officer at SKYE BIOSCIENCE, INC.
Network origin in Christopher G. Twitty first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Medical/Nursing Services | 26 | |
Public Company | Pharmaceuticals: Major | 13 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christopher G. Twitty via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal General Counsel General Counsel Corporate Officer/Principal | |
Washington University in St. Louis | College/University | Graduate Degree Undergraduate Degree | |
NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Venturi Ventures, Inc.
Venturi Ventures, Inc. Medical SpecialtiesHealth Technology Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada. | Medical Specialties | Director/Board Member Director/Board Member | |
FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
RANGE IMPACT, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Cocoon Biotech, Inc.
Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Vium, Inc.
Vium, Inc. Information Technology ServicesTechnology Services Vium, Inc. provides technology for preclinical drug discovery services. It offers biomedical investigators with technology that accelerates the preclinical drug discovery and development pipeline. The company was founded by Timothy L. Robertson and Jonathan Betts-Lacroix in 2013 and is headquartered in San Mateo, CA. | Information Technology Services | Chairman | |
University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree | |
SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
PharmaNet, Inc.
PharmaNet, Inc. Medical DistributorsDistribution Services PharmaNet, Inc. researches and develops new drugs and provides clinical development & consulting services. Its services include strategic planning, data management, bio-statistics, site management, study monitoring, protocol/CRF design, project management, information technology, quality control and assurance and regulatory affairs. The company was founded in 1996 by Jeffrey P. McMullen and is headquartered in Princeton, NJ. | Medical Distributors | Corporate Officer/Principal General Counsel | |
University of British Columbia | College/University | Doctorate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
The University of North Carolina at Chapel Hill | College/University | Masters Business Admin Doctorate Degree | |
AMBRX INC | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director of Finance/CFO General Counsel | |
London School of Hygiene & Tropical Medicine | College/University | Corporate Officer/Principal | |
Women in Bio, Inc.
Women in Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Women in Bio, Inc. is an organization that supports women in the life sciences industry. The non-profit company is based in Bethesda, MD and has subsidiaries in the United States. The organization has 13 chapters in the United States and is funded by sponsors and partners who are dedicated to supporting diversity and inclusion for women of all ages. Founded in 2002, it offers professional educational programs, peer-to-peer learning, mentoring, and networking opportunities for women at all career levels. Women in Bio was founded by Faith L. Charles and Cynthia Wong Hu. | Miscellaneous Commercial Services | Director/Board Member | |
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Chairman Chief Executive Officer | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
ARCH THERAPEUTICS, INC. | Medical Distributors | Chairman Director/Board Member | |
EMERALD HEALTH THERAPEUTICS | Agricultural Commodities/Milling | Chief Executive Officer Director/Board Member Director/Board Member | |
Coqual
Coqual Miscellaneous Commercial ServicesCommercial Services Coqual, formerly known as the Center for Talent Innovation, is a nonprofit think tank that helps leaders create diverse, equitable, and inclusive workplaces. The non-profit company is based in New York, NY, and was founded by Sylvia Ann Hewlett. The company focuses on conducting cutting-edge research and providing advisory services on various identities, including gender, race, ethnicity, disability, veteran status, and LGBTQ. Coqual was founded in 2004 and offers in-depth research, thought leadership, and data-driven solutions to address bias and barriers to inclusion for underrepresented populations in the workplace. Lanaya Irvin has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
PlaqueTec Ltd.
PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
MedCity Ltd. | Director/Board Member | ||
iOX Therapeutics Ltd.
iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
AVROBIO, INC. | Biotechnology | Director/Board Member | |
ONCIMMUNE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Emerald Health Sciences, Inc.
Emerald Health Sciences, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Sciences, Inc. develops cannabinoid pharmaceutical drugs. It targets botanicals including medical & recreational and nutraceutical segments. The company was founded on July 31 2007is headquartered in Victoria, Canada. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Emerald Health Pharmaceuticals, Inc.
Emerald Health Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Pharmaceuticals, Inc. engages in the development of medicines based on cannabinoid science. It focuses on discovering, developing, and commercializing proprietary cannabinoid-derived medicines. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Emerald Health Bioceuticals, Inc.
Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Emerald Health Bioceuticals, Inc. engages in the provision of research and development of cannabis-free nutritional supplements that support the body’s endocannabinoid system (ECS). Its products include Endo Omega, Endo OmegaVegan, Endo Immune, Endo Sleep, Endo Bliss, Endo Calm, Endo Inflame, and Endo Brain. The company was founded on March 27, 2015 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Chairman Chairman President | |
SYNEOS HEALTH, INC. | Biotechnology | General Counsel Corporate Officer/Principal | |
Thrombolytic Science International LLC
Thrombolytic Science International LLC Pharmaceuticals: MajorHealth Technology Thrombolytic Science International LLC operates as a vascular medicine and biotech company. The company was founded by Alexis Wallace and Victor Gurewich and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
PhESi LLC
PhESi LLC Pharmaceuticals: MajorHealth Technology PhESi LLC provides drug and clinical development services for life sciences companies. The private company is based in East Lyme. | Pharmaceuticals: Major | Director/Board Member | |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman | |
COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member | |
SEELOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
The Conduit Connect Ltd.
The Conduit Connect Ltd. Internet Software/ServicesTechnology Services The Conduit Connect Ltd. is a private membership platform for high net worth, sophisticated, and professional impact investors. The company is based in London, UK. The British company connects founders who are building scalable, for-profit, impact-driven businesses to capital and expert resources. The company source and connects the most promising high growth impact investing opportunities to mission-aligned investors. The company was founded in 2018, and the CEO is Eva-Maria Dimitriadis. | Internet Software/Services | Chairman | |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Founder | |
Radionetics Oncology, Inc.
Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistics
International
United States | 34 |
United Kingdom | 11 |
Canada | 6 |
Ireland | 2 |
Sectoral
Health Technology | 31 |
Consumer Services | 7 |
Commercial Services | 7 |
Technology Services | 3 |
Distribution Services | 3 |
Operational
Director/Board Member | 186 |
Corporate Officer/Principal | 104 |
Chief Executive Officer | 52 |
President | 51 |
Independent Dir/Board Member | 46 |
Most connected contacts
Insiders | |
---|---|
Annalisa Jenkins | 51 |
Andrew Schwab | 45 |
Anthony Maida | 32 |
Avtar Dhillon | 25 |
Praveen Tyle | 23 |
Daniel O'Connor | 22 |
Paul Grayson | 21 |
Bob Rai | 19 |
Gregory Mayes | 18 |
Punit Dhillon | 15 |
Margaret Dalesandro | 13 |
Robert E. Ward | 13 |
Sharron E. Gargosky | 12 |
Sheela Mohan-Peterson | 11 |
Richard B. Slansky | 10 |
- Stock Market
- Insiders
- Christopher G. Twitty
- Company connections